The Use of Extracellular Membrane Vesicles for Immunization against Francisellosis in Nile Tilapia (<i>Oreochromis niloticus</i>) and Atlantic Cod (<i>Gadus morhua</i> L.)
Verena Mertes,
Alexander Kashulin Bekkelund,
Leidy Lagos,
Elia Ciani,
Duncan Colquhoun,
Hanne Haslene-Hox,
Håvard Sletta,
Henning Sørum,
Hanne Cecilie Winther-Larsen
Affiliations
Verena Mertes
Section of Pharmacology and Pharmaceutical Biosciences and Centre of Integrative Microbial Evolution, Department of Pharmacy, University of Oslo, 0315 Oslo, Norway
Alexander Kashulin Bekkelund
Department of Food Safety and Infection Biology, Norwegian University of Life Sciences, 1430 Ås, Norway
Leidy Lagos
Section of Pharmacology and Pharmaceutical Biosciences and Centre of Integrative Microbial Evolution, Department of Pharmacy, University of Oslo, 0315 Oslo, Norway
Elia Ciani
Section of Pharmacology and Pharmaceutical Biosciences and Centre of Integrative Microbial Evolution, Department of Pharmacy, University of Oslo, 0315 Oslo, Norway
Duncan Colquhoun
Fish Health Research Group, Norwegian Veterinary Institute, 4045 Oslo, Norway
Hanne Haslene-Hox
Department of Biotechnology and Nanomedicine, SINTEF Industry, 7034 Trondheim, Norway
Håvard Sletta
Department of Biotechnology and Nanomedicine, SINTEF Industry, 7034 Trondheim, Norway
Henning Sørum
Department of Food Safety and Infection Biology, Norwegian University of Life Sciences, 1430 Ås, Norway
Hanne Cecilie Winther-Larsen
Section of Pharmacology and Pharmaceutical Biosciences and Centre of Integrative Microbial Evolution, Department of Pharmacy, University of Oslo, 0315 Oslo, Norway
Francisellosis in fish is caused by the facultative intracellular Gram-negative bacterial pathogens Francisella noatunensis ssp. noatunensis and Francisella orientalis. The disease is affecting both farmed and wild fish worldwide and no commercial vaccines are currently available. In this study, we tested isolated membrane vesicles (MVs) as possible vaccine candidates based on previous trials in zebrafish (Danio rerio) indicating promising vaccine efficacy. Here, the MV vaccine-candidates were tested in their natural hosts, Atlantic cod (Gadus morhua L.) and Nile tilapia (Oreochromis niloticus). Injection of MVs did not display any toxicity or other negative influence on the fish and gene expression analysis indicated an influence on the host immune response. However, unlike in other tested fish species, a protective immunity following vaccine application and immunization period could not be detected in the Atlantic cod or tilapia. Further in vivo studies are required to achieve a better understanding of the development of immunological memory in different fish species.